Evidence map›Paper›PMID 42911927›Full record

ArticlePhysical chemistry chemical physics : PCCP2026

Sequential structural changes in the monomeric LOV histidine kinase EL346 revealed by transient infrared spectroscopy.

Philipp Janke, Raoul E Herzog, Philipp J Heckmeier, Peter Hamm

Abstract read
In one paragraph

Article in Physical chemistry chemical physics : PCCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philipp JankeDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. philipp.janke@chem.uzh.ch.ORCID http://orcid.org/0000-0002-8508-8069
Raoul E HerzogDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. philipp.janke@chem.uzh.ch.ORCID http://orcid.org/0009-0009-1944-8490
Philipp J HeckmeierDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. philipp.janke@chem.uzh.ch.ORCID http://orcid.org/0000-0002-7311-977X
Peter HammDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. philipp.janke@chem.uzh.ch.ORCID http://orcid.org/0000-0003-1106-6032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-oxygen-voltage (LOV) domains are flavin-binding photoreceptors that mediate cellular responses to blue light. They often act as a structural switch in multidomain proteins to facilitate signaling, where the precise mechanism is dictated by the specific multidomain architecture. A few different LOV signaling models have been categorized, but an understanding of LOV signaling remains a challenge in the field. We studied the multidomain photoreceptor EL346, which couples a LOV domain to a histidine kinase effector domain. Its unique monomeric structure sets it apart from classical, dimeric LOV histidine kinases that act through a structurally entirely different pathway. We present transient infrared spectroscopy data that reveal the timescales on which activation takes place. By studying the isolated core LOV domain, we were able to isolate signal contributions originating from the histidine kinase output domain. The data reveal α-helical structural rearrangements that appear concomitantly with adduct formation at ∼10 µs. We identified a second kinetic step at ∼3 ms, where α-helical elements undergo a final structural adaptation. Our data put the sequence of structural events during the activation of EL346 into context with other LOV multidomain signaling modes, supporting a mechanism similar to

Identifiers

PMID42911927
PMCPMC13690264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.